nodes	percent_of_prediction	percent_of_DWPC	metapath
Enalapril—ABCB1—Topotecan—cervical cancer	0.525	0.625	CbGbCtD
Enalapril—CYP3A4—Topotecan—cervical cancer	0.315	0.375	CbGbCtD
Enalapril—Benazepril—MTHFR—cervical cancer	0.00808	1	CrCbGaD
Enalapril—SLC22A7—renal system—cervical cancer	0.00803	0.0802	CbGeAlD
Enalapril—SLC15A1—epithelium—cervical cancer	0.00696	0.0695	CbGeAlD
Enalapril—SLC15A1—renal system—cervical cancer	0.00645	0.0644	CbGeAlD
Enalapril—SLC15A1—endometrium—cervical cancer	0.00624	0.0623	CbGeAlD
Enalapril—SLC15A1—mammalian vulva—cervical cancer	0.00603	0.0603	CbGeAlD
Enalapril—ACE—epithelium—cervical cancer	0.00499	0.0498	CbGeAlD
Enalapril—SLCO1A2—renal system—cervical cancer	0.00486	0.0485	CbGeAlD
Enalapril—ACE—decidua—cervical cancer	0.00471	0.047	CbGeAlD
Enalapril—SLC15A1—vagina—cervical cancer	0.00467	0.0467	CbGeAlD
Enalapril—SLC22A8—renal system—cervical cancer	0.00464	0.0463	CbGeAlD
Enalapril—ACE—renal system—cervical cancer	0.00463	0.0462	CbGeAlD
Enalapril—ACE—endometrium—cervical cancer	0.00447	0.0447	CbGeAlD
Enalapril—ACE—mammalian vulva—cervical cancer	0.00433	0.0432	CbGeAlD
Enalapril—ACE—female reproductive system—cervical cancer	0.0037	0.037	CbGeAlD
Enalapril—ACE—female gonad—cervical cancer	0.00337	0.0337	CbGeAlD
Enalapril—Pulmonary embolism—Topotecan—cervical cancer	0.00269	0.0517	CcSEcCtD
Enalapril—CYP3A4—renal system—cervical cancer	0.0023	0.023	CbGeAlD
Enalapril—ACE—lymph node—cervical cancer	0.00217	0.0216	CbGeAlD
Enalapril—Anaphylactoid reaction—Topotecan—cervical cancer	0.00201	0.0388	CcSEcCtD
Enalapril—Cardiac arrest—Topotecan—cervical cancer	0.00185	0.0357	CcSEcCtD
Enalapril—CYP3A4—female reproductive system—cervical cancer	0.00184	0.0184	CbGeAlD
Enalapril—Cramp muscle—Topotecan—cervical cancer	0.00176	0.0338	CcSEcCtD
Enalapril—ABCB1—epithelium—cervical cancer	0.00176	0.0175	CbGeAlD
Enalapril—ABCB1—uterine cervix—cervical cancer	0.00174	0.0174	CbGeAlD
Enalapril—Alanine aminotransferase increased—Topotecan—cervical cancer	0.00172	0.0331	CcSEcCtD
Enalapril—ABCB1—decidua—cervical cancer	0.00166	0.0166	CbGeAlD
Enalapril—ABCB1—renal system—cervical cancer	0.00163	0.0163	CbGeAlD
Enalapril—Pancytopenia—Topotecan—cervical cancer	0.0016	0.0308	CcSEcCtD
Enalapril—Neutropenia—Topotecan—cervical cancer	0.00158	0.0303	CcSEcCtD
Enalapril—ABCB1—endometrium—cervical cancer	0.00157	0.0157	CbGeAlD
Enalapril—ABCB1—mammalian vulva—cervical cancer	0.00152	0.0152	CbGeAlD
Enalapril—Pneumonia—Topotecan—cervical cancer	0.00151	0.0291	CcSEcCtD
Enalapril—Neuropathy peripheral—Topotecan—cervical cancer	0.00147	0.0284	CcSEcCtD
Enalapril—Stomatitis—Topotecan—cervical cancer	0.00146	0.0282	CcSEcCtD
Enalapril—ABCB1—uterus—cervical cancer	0.00145	0.0145	CbGeAlD
Enalapril—Epistaxis—Topotecan—cervical cancer	0.00142	0.0273	CcSEcCtD
Enalapril—Pharyngitis—Topotecan—cervical cancer	0.00134	0.0258	CcSEcCtD
Enalapril—ABCB1—female reproductive system—cervical cancer	0.0013	0.013	CbGeAlD
Enalapril—Alopecia—Topotecan—cervical cancer	0.00119	0.0229	CcSEcCtD
Enalapril—ABCB1—female gonad—cervical cancer	0.00119	0.0119	CbGeAlD
Enalapril—ABCB1—vagina—cervical cancer	0.00118	0.0118	CbGeAlD
Enalapril—Back pain—Topotecan—cervical cancer	0.00114	0.0219	CcSEcCtD
Enalapril—Muscle spasms—Topotecan—cervical cancer	0.00113	0.0217	CcSEcCtD
Enalapril—Anaemia—Topotecan—cervical cancer	0.00109	0.0209	CcSEcCtD
Enalapril—Angioedema—Topotecan—cervical cancer	0.00107	0.0207	CcSEcCtD
Enalapril—Leukopenia—Topotecan—cervical cancer	0.00105	0.0202	CcSEcCtD
Enalapril—Cough—Topotecan—cervical cancer	0.00102	0.0197	CcSEcCtD
Enalapril—Arthralgia—Topotecan—cervical cancer	0.001	0.0192	CcSEcCtD
Enalapril—Chest pain—Topotecan—cervical cancer	0.001	0.0192	CcSEcCtD
Enalapril—Myalgia—Topotecan—cervical cancer	0.001	0.0192	CcSEcCtD
Enalapril—Discomfort—Topotecan—cervical cancer	0.000988	0.019	CcSEcCtD
Enalapril—Anaphylactic shock—Topotecan—cervical cancer	0.000958	0.0185	CcSEcCtD
Enalapril—Thrombocytopenia—Topotecan—cervical cancer	0.000938	0.0181	CcSEcCtD
Enalapril—Hyperhidrosis—Topotecan—cervical cancer	0.000927	0.0178	CcSEcCtD
Enalapril—Anorexia—Topotecan—cervical cancer	0.000914	0.0176	CcSEcCtD
Enalapril—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000873	0.0168	CcSEcCtD
Enalapril—Paraesthesia—Topotecan—cervical cancer	0.000861	0.0166	CcSEcCtD
Enalapril—Dyspnoea—Topotecan—cervical cancer	0.000854	0.0164	CcSEcCtD
Enalapril—Dyspepsia—Topotecan—cervical cancer	0.000844	0.0162	CcSEcCtD
Enalapril—Decreased appetite—Topotecan—cervical cancer	0.000833	0.016	CcSEcCtD
Enalapril—Fatigue—Topotecan—cervical cancer	0.000826	0.0159	CcSEcCtD
Enalapril—Constipation—Topotecan—cervical cancer	0.00082	0.0158	CcSEcCtD
Enalapril—Feeling abnormal—Topotecan—cervical cancer	0.00079	0.0152	CcSEcCtD
Enalapril—Gastrointestinal pain—Topotecan—cervical cancer	0.000784	0.0151	CcSEcCtD
Enalapril—ABCB1—lymph node—cervical cancer	0.000763	0.00762	CbGeAlD
Enalapril—Urticaria—Topotecan—cervical cancer	0.000761	0.0147	CcSEcCtD
Enalapril—Abdominal pain—Topotecan—cervical cancer	0.000758	0.0146	CcSEcCtD
Enalapril—Body temperature increased—Topotecan—cervical cancer	0.000758	0.0146	CcSEcCtD
Enalapril—Hypersensitivity—Topotecan—cervical cancer	0.000706	0.0136	CcSEcCtD
Enalapril—Asthenia—Topotecan—cervical cancer	0.000688	0.0132	CcSEcCtD
Enalapril—Pruritus—Topotecan—cervical cancer	0.000678	0.0131	CcSEcCtD
Enalapril—Diarrhoea—Topotecan—cervical cancer	0.000656	0.0126	CcSEcCtD
Enalapril—Dizziness—Topotecan—cervical cancer	0.000634	0.0122	CcSEcCtD
Enalapril—Vomiting—Topotecan—cervical cancer	0.000609	0.0117	CcSEcCtD
Enalapril—Rash—Topotecan—cervical cancer	0.000604	0.0116	CcSEcCtD
Enalapril—Dermatitis—Topotecan—cervical cancer	0.000604	0.0116	CcSEcCtD
Enalapril—Headache—Topotecan—cervical cancer	0.0006	0.0116	CcSEcCtD
Enalapril—Nausea—Topotecan—cervical cancer	0.000569	0.011	CcSEcCtD
